Bret Bostwick

Bret Bostwick, MD, FAAP, FACMG, is an accomplished physician with a diverse background in pediatrics and medical genetics. After earning a Doctor of Medicine degree from the University of Wisconsin-Madison in 2011, Bret completed residency training at Baylor College of Medicine, serving in various roles including Assistant Professor and Postdoctoral Research Fellow. Bret has been a Fellow of the American Board of Medical Genetics and Genomics since 2017 and a Fellow of the American Academy of Pediatrics. Notably, Bret held the position of Chief of Pediatric Genetics at Texas Children's Hospital from 2017 to 2019 and has since contributed as a Senior Medical Director at Alnylam Pharmaceuticals and Principal at Translational Medicine Solutions. Currently, Bret serves as an AI Advisor at Meta, a Venture Advisor at Breyer Capital, and an Independent Consultant at Bostwick Consulting, LLC.